Screener
Immunovant, Inc. IMVT PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026.
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
| Line item | March 31, 2026 | March 31, 2025 |
|---|---|---|
| Income tax receivable | 2,813 | 427 |
| Total current assets | 948,819 | 767,662 |
| Operating lease right-of-use assets | 72 | 98 |
| Property and equipment, net | 443 | 844 |
| Other assets | 7,680 | 7,618 |
| Total assets | $957,014 | $776,222 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Immunovant, Inc.'s PP&E (net)?
- Immunovant, Inc. (IMVT) reported PP&E (net) of $443K in Q1 2026.
- How has Immunovant, Inc.'s PP&E (net) changed year-over-year?
- Immunovant, Inc.'s PP&E (net) decreased by 47.5% year-over-year, from $844K to $443K.
- What is the long-term trend for Immunovant, Inc.'s PP&E (net)?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s PP&E (net) has grown at a 17.1% compound annual growth rate (CAGR), from $201K to $443K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Immunovant, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude